LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | 0.1 | 67.2 | 571.5 | 46.7 | 0.1 | - | - | 685.7 |
1 | - | - | - | - | 79.3 | 144.9 | 1.3 | 0.0 | - | - | 225.5 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 0.3 |
1 | - |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | - |
1 | - |
Number of post synapses: 15770
Number of pre synapses: 5187
Number of output connections: 19536
Coverage factor: 2.4
Columnar completeness: 0.95
Area completeness: 0.96
Cell size (columns): 82
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#Cm11c (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Dm2 (R) | ACh | 6,479 | 281.7 | 41.8% | 41.8% |
1 | Tm5b (R) | ACh | 1,901 | 82.7 | 12.3% | 54.0% |
2 | MeVPMe13 (L) | ACh | 791 | 34.4 | 5.1% | 59.1% |
3 | MeVC20 (R) | Glu | 659 | 28.7 | 4.2% | 63.3% |
4 | Cm7 (R) | Glu | 603 | 26.2 | 3.9% | 67.2% |
5 | Cm27 (R) | Glu | 519 | 22.6 | 3.3% | 70.6% |
6 | MeVC22 (R) | Glu | 474 | 20.6 | 3.1% | 73.6% |
7 | Cm20 (R) | GABA | 300 | 13.0 | 1.9% | 75.6% |
8 | MeTu3b (R) | ACh | 267 | 11.6 | 1.7% | 77.3% |
9 | Cm28 (R) | unclear | 266 | 11.6 | 1.7% | 79.0% |
10 | Mi10 (R) | ACh | 222 | 9.7 | 1.4% | 80.4% |
11 | MeLo4 (R) | ACh | 179 | 7.8 | 1.2% | 81.6% |
12 | MeTu3c (R) | ACh | 179 | 7.8 | 1.2% | 82.7% |
13 | MeVPLo2 (R) | ACh | 171 | 7.4 | 1.1% | 83.8% |
14 | Tm40 (R) | ACh | 148 | 6.4 | 1.0% | 84.8% |
15 | Tm5a (R) | ACh | 139 | 6.0 | 0.9% | 85.7% |
16 | MeVPMe13 (R) | ACh | 129 | 5.6 | 0.8% | 86.5% |
17 | MeVPMe7 (L) | Glu | 121 | 5.3 | 0.8% | 87.3% |
18 | Dm9 (R) | Glu | 113 | 4.9 | 0.7% | 88.0% |
19 | Tm29 (R) | Glu | 106 | 4.6 | 0.7% | 88.7% |
20 | Mi15 (R) | ACh | 104 | 4.5 | 0.7% | 89.4% |
21 | MeTu1 (R) | ACh | 101 | 4.4 | 0.7% | 90.0% |
22 | Dm8b (R) | Glu | 97 | 4.2 | 0.6% | 90.7% |
23 | MeVP15 (R) | ACh | 92 | 4.0 | 0.6% | 91.2% |
24 | Cm2 (R) | ACh | 88 | 3.8 | 0.6% | 91.8% |
25 | MeVP6 (R) | Glu | 70 | 3.0 | 0.5% | 92.3% |
26 | OA-AL2i4 (R) | OA | 68 | 3.0 | 0.4% | 92.7% |
27 | Cm1 (R) | ACh | 56 | 2.4 | 0.4% | 93.1% |
28 | Dm8a (R) | Glu | 51 | 2.2 | 0.3% | 93.4% |
29 | TmY5a (R) | Glu | 49 | 2.1 | 0.3% | 93.7% |
30 | Dm11 (R) | Glu | 48 | 2.1 | 0.3% | 94.0% |
31 | Cm31a (R) | GABA | 46 | 2.0 | 0.3% | 94.3% |
32 | MeVPMe7 (R) | Glu | 46 | 2.0 | 0.3% | 94.6% |
33 | Cm3 (R) | GABA | 41 | 1.8 | 0.3% | 94.9% |
34 | aMe30 (R) | Glu | 35 | 1.5 | 0.2% | 95.1% |
35 | MeTu3a (R) | ACh | 31 | 1.3 | 0.2% | 95.3% |
36 | Cm9 (R) | Glu | 28 | 1.2 | 0.2% | 95.5% |
37 | MeVC25 (R) | Glu | 28 | 1.2 | 0.2% | 95.7% |
38 | Cm11a (R) | ACh | 27 | 1.2 | 0.2% | 95.8% |
39 | MeVC5 (L) | ACh | 27 | 1.2 | 0.2% | 96.0% |
40 | MeVC6 (L) | ACh | 26 | 1.1 | 0.2% | 96.2% |
41 | Cm5 (R) | GABA | 25 | 1.1 | 0.2% | 96.3% |
42 | Cm34 (R) | Glu | 23 | 1.0 | 0.1% | 96.5% |
instance | NT | total connections | connections /#Cm11c (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Dm11 (R) | Glu | 4,257 | 185.1 | 21.8% | 21.8% |
1 | Dm8b (R) | Glu | 4,219 | 183.4 | 21.6% | 43.4% |
2 | Dm8a (R) | Glu | 3,967 | 172.5 | 20.3% | 63.7% |
3 | Dm4 (R) | Glu | 3,932 | 171.0 | 20.1% | 83.8% |
4 | MeVPLo2 (R) | ACh | 653 | 28.4 | 3.3% | 87.2% |
5 | TmY18 (R) | ACh | 374 | 16.3 | 1.9% | 89.1% |
6 | Cm5 (R) | GABA | 287 | 12.5 | 1.5% | 90.6% |
7 | Dm-DRA2 (R) | Glu | 245 | 10.7 | 1.3% | 91.8% |
8 | Dm-DRA1 (R) | Glu | 164 | 7.1 | 0.8% | 92.7% |
9 | Dm9 (R) | Glu | 161 | 7.0 | 0.8% | 93.5% |
10 | Tm5b (R) | ACh | 138 | 6.0 | 0.7% | 94.2% |
11 | Cm4 (R) | Glu | 118 | 5.1 | 0.6% | 94.8% |
12 | MeTu3b (R) | ACh | 67 | 2.9 | 0.3% | 95.1% |
13 | Dm2 (R) | ACh | 66 | 2.9 | 0.3% | 95.5% |
14 | Cm1 (R) | ACh | 56 | 2.4 | 0.3% | 95.8% |
15 | MeVPMe13 (R) | ACh | 48 | 2.1 | 0.2% | 96.0% |
16 | Cm11a (R) | ACh | 41 | 1.8 | 0.2% | 96.2% |
17 | MeVPMe3 (R) | Glu | 40 | 1.7 | 0.2% | 96.4% |
18 | MeVPMe13 (L) | ACh | 38 | 1.7 | 0.2% | 96.6% |
19 | Cm3 (R) | GABA | 32 | 1.4 | 0.2% | 96.8% |
20 | aMe4 (R) | ACh | 30 | 1.3 | 0.2% | 96.9% |
21 | Cm11b (R) | ACh | 24 | 1.0 | 0.1% | 97.1% |